Serum VEGF-A and CCL5 levels as candidate biomarkers for efficacy and toxicity of regorafenib in patients with metastatic colorectal cancer-Reference-Cited by-同舟云学术

Serum VEGF-A and CCL5 levels as candidate biomarkers for efficacy and toxicity of regorafenib in patients with metastatic colorectal cancer

Published:2016-05-05 Issue:23 Volume:7 Page:34811-34823
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Suenaga Mitsukuni¹,Mashima Tetsuo²,Kawata Naomi¹²,Wakatsuki Takeru¹,Horiike Yuki¹,Matsusaka Satoshi¹,Dan Shingo³,Shinozaki Eiji¹,Seimiya Hiroyuki²,Mizunuma Nobuyuki¹,Yamaguchi Kensei¹,Yamaguchi Toshiharu⁴

Affiliation:

1. Department of Gastroenterological and Chemotherapy Cancer Institute Hospital of Japanese Foundation for Cancer Research, Koto-ku, Tokyo 135-8550, Japan

2. Division of Molecular Biotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Koto-ku, Tokyo 135-8550, Japan

3. Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Koto-ku, Tokyo 135-8550, Japan

4. Department of Gastroenterological and Surgery Cancer Institute Hospital of Japanese Foundation for Cancer Research, Koto-ku, Tokyo 135-8550, Japan

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploratory Study Identifies Matrix Metalloproteinase-14 and -9 as Potential Biomarkers of Regorafenib Efficacy in Metastatic Colorectal Cancer;Cancers;2024-08-15

2. Association of VEGFA and CCL4L2 polymorphisms with hand-foot skin reaction and survival of regorafenib in Japanese patients with colorectal cancer;Cancer Chemotherapy and Pharmacology;2024-03-08

3. The Role and Therapeutic Targeting of CCR5 in Breast Cancer;Cells;2023-09-08

4. The Relationship of CCL5 and CCR1 Variants with Response Rate and Survival Taking into Account Thalidomide/Bortezomib Treatment in Patients with Multiple Myeloma;Journal of Clinical Medicine;2023-03-20

5. Tumor Immunogenic Cell Death as a Mediator of Intratumor CD8 T-Cell Recruitment;Cells;2022-11-18